Product Pathways - Cytoskeletal Signaling
Phospho-Myosin Light Chain 2 (Thr18/Ser19) Antibody #3674
|3674S||100 µl (10 western blots)||---||In Stock||---|
|3674P||40 µl (4 western blots)||---||In Stock||---|
|3674||carrier free and custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Species predicted to react based on 100% sequence homology: Rat, Chicken, Xenopus, Zebrafish, Bovine, Pig.
Specificity / Sensitivity
Phospho-Myosin Light Chain 2 (Thr18/Ser19) Antibody detects endogenous levels of myosin light chain 2 (smooth muscle) only when dually phosphorylated at threonine 18 and serine 19. The antibody does not cross-react with the cardiac isoform of myosin light chain 2.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr18/Ser19 of human myosin light chain 2. Antibodies are purified by protein A and peptide affinity chromatography.
Myosin is composed of six polypeptide chains: two identical heavy chains and two pairs of light chains. Myosin light chain 2 (MLC2), also known as myosin regulatory light chain (MRLC), RLC, or LC20, has many isoforms depending on its distribution. In smooth muscle, MLC2 is phosphorylated at Thr18 and Ser19 by myosin light chain kinase (MLCK) in a Ca2+/calmodulin-dependent manner (1). This phosphorylation is correlated with myosin ATPase activity and smooth muscle contraction (2). ROCK also phosphorylates Ser19 of smooth muscle MLC2, which regulates the assembly of stress fibers (3). Phosphorylation of smooth muscle MLC2 at Ser1/Ser2 and Ser9 by PKC and cdc2 has been reported to inhibit myosin ATPase activity (4,5). Phosphorylation by cdc2 controls the timing of cytokinesis (5). Transgenic mice lacking phosphorylation sites on the cardiac muscle isoform show morphological and functional abnormalities (6).
- Ikebe, M. and Hartshorne, D.J. (1985) J. Biol. Chem. 260, 10027-10031.
- Tan, J. L. et al. (1992) Annu. Rev. Biochem. 61, 721-759.
- Totsukawa, G. et al. (2000) J. Cell Biol. 150, 797-806.
- Ikebe, M. et al. (2000) J. Biol. Chem. 262, 9569-9573.
- Satterwhite, L. L. et al. (1992) J. Cell Biol. 118, 595-605.
- Sanbe, A. et al. (1999) J. Biol. Chem. 274, 21085-21094.
- Birukova, A. A. et al. (2004) . J. Cellular Phys. 201, 55-50. Applications: IC-IF, Western Blotting.
- Watanabe, T. et al. (2007) Mol Biol Cell 18, 605-16. Applications: Western Blotting.
- Bhadriraju, K. et al. (2007) BMC Cell Biol 8, 43. Applications: IF-IC (In Cells), Western Blotting.
- Ponsaerts, R. et al. (2008) Invest Ophthalmol Vis Sci 49, 4816-27. Applications: IF-IC (In Cells).
- Li, Z. et al. (2006) Mol Cell Biol 26, 4240-56. Applications: Western Blotting.
- Rajagopalan, L.E. et al. (2010) J Pharmacol Exp Ther 333, 707-16. Applications: Fluorescent Detection.
- Hudson, C.A. et al. (2012) Mol Hum Reprod 18, 265-79. Applications: Western Blotting.
- Ramachandran, C. et al. (2011) Invest Ophthalmol Vis Sci 52, 1474-85. Applications: IF-IC (In Cells), Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 8505 Myosin Light Chain 2 (D18E2) Rabbit mAb
- 3672 Myosin Light Chain 2 Antibody
- 3671 Phospho-Myosin Light Chain 2 (Ser19) Antibody
- 3675 Phospho-Myosin Light Chain 2 (Ser19) Mouse mAb
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.